SSI: Revolutionizing Breast Cancer Detection, but Slowly
Executive Summary
Building off conventional ultrasound technology, France's SSI hopes to change the way breast cancer detection is done, reducing the number of unnecessary biopsies by employing elastography to register the stiffness of breast tissue. But as the company seeks to challenge a 3000 year old, low tech approach--manual palpation--company officials are proceeding slowly and are cautious about the claims they make for their technology's innovativeness.
You may also be interested in...
ASBS 2010: Economy, Rise in Mastectomies Temper Minimally Invasive Advancements in Breast Care
Surgeons attending the 11th annual meeting of the American Society of Breast Surgeons were perplexed by the reversal of the trend away from mastectomy and toward breast-conserving therapies. Advanced breast-conserving products were presented at the meeting; but with lowered revenue expectations that can ultimately be attributed to the economic woes of the past couple of years. High unemployment and the lack of health care coverage have prompted many women to delay or forego their yearly mammogram, and as a result, the numbers of biopsies, surgeries, and radiation therapy procedures have declined as well.
Task Force Mammography Guidelines Present Challenges And Opportunities
Mammography coverage policies among public and private payers are not likely to be restricted, at least in the near term, by the U.S. Preventive Services Task Force's new breast cancer screening guidelines, but prospects for longer-term adjustments remain
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”